Mind + Muscle

technical minds + legal muscle


dig deep

US Biosimilar Biologics – The Ship has Sailed

  • 10.30.14
  • Paul A. Calvo, Ph.D. and Timothy J. Shea, Jr.
  • European Biotechnology News

In this European Biotechnology News IP Flash article Paul A. Calvo, Ph.D. and Timothy J. Shea, Jr. provide an overview of recent activity related to biosimilar biologics at the U.S Food and Drug Administration and the Court of Appeals for the Federal Circuit. The duo highlights the recent success of generic biologic manufactures and asserts that "the era of generic biologic drugs has officially begun."

To read the full article, please download the attached PDF.

Related People

Related Industries

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.